Delivery Order SPE2DB22D3004-SPE2DB25FPV52

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp from the Defense Logistics Agency (DLA) is for the delivery of Estradiol 0.01% Cream, 42.5 grams, valued at $1,169.99. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is a $999,999,999 contract running through November 2026. This IDC serves as a primary vehicle for the company to provide a broad range of pharmaceutical products and...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for the supply of Estradiol 0.01% cream. The contract has a ceiling value of $1,708.33 and a period of performance through April 3, 2023. Amerisourcebergen, a major pharmaceutical distributor, has a significant IDC with DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $1,887.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Estradiol 0.01% cream, a prescription medication, with a completion date of June 4, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.39 Firm Fixed Price Delivery Order contract is for the supply of ESTRADIOL VALERATE 200 MG/5 ML 5ML, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,940.15 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, with a completion date of July 24, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is a delivery order (SPE2DB22D1017|SPE2DB24FF3AK) with a ceiling value of $2,415.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrace 0.01% cream, a prescription medication, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FMARU, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,400.20 firm fixed-price delivery order is for Estrace 0.01% cream, 42.5g, with a completion date of September 4, 2024. The contract is not designated with a set-aside and represents an open competition award. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Estrace 0.01% Cream, a pharmaceutical product, with a ceiling value of $1,331.41 and a completion date of March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estrace 0.01% Cream in 42.5 gram units. The contract has a firm fixed price, with a ceiling value of $1,249.26, and an ultimate completion date of July 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ESTRACE 0.01% CREAM 42.5GM, with a ceiling value of $1,617.10 and a period of performance through February 2025. This contract is a firm fixed-price, delivery order type, and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPV52
    Delivery Order

This federal contract award, SPE2DB22D3004|SPE2DB25FPV52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estradiol 0.01% Cream, a pharmaceutical product, with a ceiling value of $2,724.46. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 11, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/9/25, 9:49 AM